C-type natriuretic peptide as a new regulator of food intake and energy expenditure

Endocrinology

Volumn 151, Issue 8, 2010, Pages 3633-3642

  Inuzuka, Megumi ^a   Tamura, Naohisa ^a   Yamada, Nobuko ^a   Katsuura, Goro ^a   Oyamada, Naofumi ^a   Taura, Daisuke ^a   Sonoyama, Takuhiro ^a   Fukunaga, Yasutomo ^a   Ohinata, Kousaku ^b   Sone, Masakatsu ^a   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; MESSENGER RNA; NATRIURETIC PEPTIDE TYPE C; NORADRENALIN; PROPRANOLOL; UNCOUPLING PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY FAT; BODY GROWTH; BODY WEIGHT; BONE DYSPLASIA; BROWN ADIPOSE TISSUE; CARTILAGE CELL; CONTROLLED STUDY; CORE TEMPERATURE; ENERGY EXPENDITURE; FOOD INTAKE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HORMONE ACTION; HYPOTHALAMUS; INSULIN TOLERANCE TEST; MALE; METABOLIC PARAMETERS; MOUSE; NONHUMAN; NORADRENALIN URINE LEVEL; OXYGEN CONSUMPTION; PHENOTYPE; PRIORITY JOURNAL; RECTUM TEMPERATURE; STARVATION; SYMPATHETIC TONE;

AGOUTI-RELATED PROTEIN; ANIMALS; APPETITE REGULATION; BODY TEMPERATURE; CHONDROCYTES; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GUANYLATE CYCLASE; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NATRIURETIC PEPTIDE, C-TYPE; NEUROPEPTIDE Y; NOREPINEPHRINE; ORGAN SPECIFICITY; PPAR GAMMA; TISSUE DISTRIBUTION; TRANS-ACTIVATORS;

EID: 77954923280     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0141     Document Type: Article

References (43)

1. Nakao K, Yasoda A, Ebihara K, Hosoda K, Mukoyama M 2009 Translational research of novel hormones: lessons from animal models and rare human diseases for common human diseases. J Mol Med 87:1029-1039
2. Suga S, Nakao K, Hosoda K, Mukoyama M, Ogawa Y, Shirakami G, Arai H, Saito Y, Kambayashi Y, Inouye K, Imura H 1992 Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 130:229-239
3. Kojima M, Minamino N, Kangawa K, Matsuo H 1990 Cloning and sequence analysis of a cDNA encoding a precursor for rat C-type natriuretic peptide (CNP). FEBS Lett 276:209-213
4. Suga S, Nakao K, Itoh H, Komatsu Y, Ogawa Y, Hama N, Imura H 1992 Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-β: possible existence of "vascular natriuretic peptide system." J Clin Invest 90:1145-1149
5. Komatsu Y, Nakao K, Itoh H, Suga S, Ogawa Y, Imura H 1992 Vascular natriuretic peptide. Lancet 340:622
6. Komatsu Y, Itoh H, Suga S, Ogawa Y, Hama N, Kishimoto I, Nakagawa O, Igaki T, Doi K, Yoshimasa Y, Nakao K 1996 Regulation of endothelial production of C-type natriuretic peptide in coculture with vascular smooth muscle cells: role of the vascular natriuretic peptide system in vascular growth inhibition. Circ Res 78:606-614
7. Chusho H, Tamura N, Ogawa Y, Yasoda A, Suda M, Miyazawa T, Nakamura K, Nakao K, Kurihara T, Komatsu Y, Itoh H, Tanaka K, Saito Y, Katsuki M, Nakao K 2001 Dwarfism and early death in mice lacking C-type natriuretic peptide. Proc Natl Acad Sci USA 98:4016-4021
8. Tamura N, Doolittle LK, Hammer RE, Shelton JM, Richardson JA, Garbers DL 2004 Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs. Proc Natl Acad Sci USA 101:17300-17305 (Pubitemid 39627814)
9. Komatsu Y, Nakao K, Suga S, Ogawa Y, Mukoyama M, Arai H, Shirakami G, Hosoda K, Nakagawa O, Hama N, Kishimoto I, Imura H 1991 C-type natriuretic peptide (CNP) in rats and humans. Endocrinology 129:1104-1106
10. Tamura N, Garbers DL 2003 Regulation of the guanylyl cyclase-B receptor by alternative splicing. J Biol Chem 278:48880-48889
11. Kishimoto I, Tokudome T, Horio T, Soeki T, Chusho H, Nakao K, Kangawa K 2008 C-type natriuretic peptide is a Schwann cell-derived factor for development and function of sensory neurones. J Neuroendocrinol 20:1213-1223
12. Berthoud HR, Morrison C 2008 The brain, appetite, and obesity. Annu Rev Psychol 59:55-92
13. Herman JP, Langub Jr MC, Watson Jr RE 1993 Localization of C-type natriuretic peptide mRNA in rat hypothalamus. Endocrinology 133:1903-1906 (Pubitemid 23295225)
14. Langub Jr MC, Dolgas CM, Watson Jr RE, Herman JP 1995 The C-type natriuretic peptide receptor is the predominant natriuretic peptide receptor mRNA expressed in rat hypothalamus. J Neuroendocrinol 7:305-309
15. Kim-Saijo M, Akamizu T, Ikuta K, Iida Y, Ohmori K, Matsubara K, Matsuda Y, Suzuki M, Matsuda F, Nakao K 2003 Generation of a transgenic animal model of hyperthyroid Graves' disease. Eur J Immunol 33:2531-2538 (Pubitemid 37138984)
16. Iwakura H, Akamizu T, Ariyasu H, Irako T, Hosoda K, Nakao K, Kangawa K 2007 Effects of ghrelin administration on decreased growth hormone status in obese animals. Am J Physiol Endocrinol Metab 293:E819-E825
17. Koide H, Shibata T, Yamada N, Asaki T, Nagao T, Yoshida T, Noguchi Y, Tanaka T, Saito Y, Tatsuno I 2007 Tumor suppressor candidate 5 (TUSC5) is expressed in brown adipocytes. Biochem Biophys Res Commun 360:139-145 (Pubitemid 46990335)
18. Ebihara K, Ogawa Y, Katsuura G, Numata Y, Masuzaki H, Satoh N, Tamaki M, Yoshioka T, Hayase M, Matsuoka N, Aizawa-Abe M, Yoshimasa Y, Nakao K 1999 Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action. Diabetes 48:2028-2033
19. Ohinata K, Inui A, Asakawa A, Yoshikawa M 2001 Novel actions of proadrenomedullin N-terminal 20 peptide (PAMP). Peptides 22:1809-1816 (Pubitemid 34062798)
20. Negishi T, Kawasaki K, Suzaki S, Maeda H, Ishii Y, Kyuwa S, Kuroda Y, Yoshikawa Y 2004 Behavioral alterations in response to fear-provoking stimuli and tranylcypromine induced by perinatal exposure to bisphenol A and nonylphenol in male rats. Environ Health Perspect 112:1159-1164 (Pubitemid 39157616)
21. Lowell BB, Spiegelman BM 2000 Towards a molecular understanding of adaptive thermogenesis. Nature 404:652-660 (Pubitemid 30205070)
22. Mascaró C, Acosta E, Ortiz JA, Marrero PF, Hegardt FG, Haro D 1998 Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor. J Biol Chem 273:8560-8563 (Pubitemid 28176129)
23. Weis BC, Cowan AT, Brown N, Foster DW, McGarry JD 1994 Use of a selective inhibitor of liver carnitine palmitoyltransferase I (CPT I) allows quantification of its contribution to total CPT I activity in rat heart. Evidence that the dominant cardiac CPT I isoform is identical to the skeletal muscle enzyme. J Biol Chem 269:26443-26448
24. Langenickel TH, Buttgereit J, Pagel-Langenickel I, Lindner M, Monti J, Beuerlein K, Al-Saadi N, Plehm R, Popova E, Tank J, Dietz R, Willenbrock R, Bader M 2006 Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B. Proc Natl Acad Sci USA 103:4735-2740
25. Madden CJ, Morrison SF 2009 Neurons in the paraventricular nucleus of the hypothalamus inhibit sympathetic outflow to brown adipose tissue. Am J Physiol Regul Integr Comp Physiol 296:R831-R843
26. Nakamura K, Morrison SF 2008 A thermosensory pathway that controls body temperature. Nat Neurosci 11:62-71
27. Langub Jr MC, Watson Jr RE, Herman JP 1995 Distribution of natriuretic peptide precursor mRNAs in the rat brain. J Comp Neurol 356:183-199
28. Vesely DL, San Miguel GI, Hassan I, Gower Jr WR, Schocken DD 2001 Atrial natriuretic hormone, vessel dilator, long-acting natriuretic hormone, and kaliuretic hormone decrease the circulating concentrations of total and free T4 and free T3 with reciprocal increase in TSH. J Clin Endocrinol Metab 86:5438-5442 (Pubitemid 33070272)
29. Müller D, Hida B, Guidone G, Speth RC, Michurina TV, Enikolopov G, Middendorff R 2009 Expression of guanylyl cyclase (GC)-A and GC-B during brain development: evidence for a role of GC-B in perinatal neurogenesis. Endocrinology 150:5520-5529
30. Simpson PJ, Miller I, Moon C, Hanlon AL, Liebl DJ, Ronnett GV 2002 Atrial natriuretic peptide type C induces a cell-cycle switch from proliferation to differentiation in brain-derived neurotrophic factor- or nerve growth factor-primed olfactory receptor neurons. J Neurosci 22:5536-5551
31. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K 1999 Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660
32. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S 2001 A role for ghrelin in the central regulation of feeding. Nature 409:194-198
33. Date Y, Murakami N, Toshinai K, Matsukura S, Niijima A, Matsuo H, Kangawa K, Nakazato M 2002 The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123:1120-1128
34. Marsh DJ, Hollopeter G, Kafer KE, Palmiter RD 1998 Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nat Med 4:718-721
35. Larhammar D, Salaneck E 2004 Molecular exolution of NPY receptor subtypes. Neuropeptides 38:141-151
36. Montani JP, Antic V, Yang Z, Dulloo A 2002 Pathways from obesity to hypertension: from the perspective of a vicious triangle. Int J Obes 26 (Suppl 2):S28-S38
37. Arch JR 2008 The discovery of drugs for obesity, the metabolic effects of leptin and variable receptor pharmacology: perspectives from β3-adrenoceptor agonists. Naunyn-Schmied Arch Pharmacol 378:225-240
38. Ogawa Y, Masuzaki H, Hosoda K, Aizawa-Abe M, Suga J, Suda M, Ebihara K, Iwai H, Matsuoka N, Satoh N, Odaka H, Kasuga H, Fujisawa Y, Inoue G, Nishimura H, Yoshimasa Y, Nakao K 1999 Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin. Diabetes 48:1822-1829
39. Masuzaki H, Ogawa Y, Aizawa-Abe M, Hosoda K, Suga J, Ebihara K, Satoh N, Iwai H, Inoue G, Nishimura H, Yoshimasa Y, Nakao K 1999 Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: usefulness of leptin for the treatment of obesity-associated diabetes. Diabetes 48:1615-1622
40. Tanaka T, Hidaka S, Masuzaki H, Yasue S, Minokoshi Y, Ebihara K, Chusho H, Ogawa Y, Toyoda T, Sato K, Miyanaga F, Fujimoto M, Tomita T, Kusakabe T, Kobayashi N, Tanioka H, Hayashi T, Hosoda K, Yoshimatsu H, Sakata T, Nakao K 2005 Skeletal muscle AMP-activated protein kinase phosphorylation parallels metabolic phenotype in leptin transgenic mice under dietary modification. Diabetes 54:2365-2374
41. Friedman JM, Halaas JL 1998 Leptin and the regulation of body weight in mammals. Nature 395:763-770 (Pubitemid 28485436)
42. Cusin I, Zakrzewska KE, Boss O, Muzzin P, Giacobino JP, Ricquier D, Jeanrenaud B, Rohner-Jeanrenaud F 1998 Chronic central leptin infusion enhances insulin-stimulated glucose metabolism and favors the expression of uncoupling proteins. Diabetes 47:1014-1019 (Pubitemid 28294541)
43. Satoh N, Ogawa Y, Katsuura G, Numata Y, Tsuji T, Hayase M, Ebihara K, Masuzaki H, Hosoda K, Yoshimasa Y, Nakao K 1999 Sympathetic activation of leptin via the ventromedial hypothalamus: leptin-induced increase in catecholamine secretion. Diabetes 48:1787-1793